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The transcription  factor  nuclear  factor KB (NF-KB) is 
sequestered in the  cytoplasm  of  most  cell  types  where  it 
is complexed  with its inhibitor  (IKB). A large  variety  of 
agents,  including  growth  factors,  the  tumor  promoter 
phorbol12-myristate  13-acetate,  and  the  cytokine  tumor 
necrosis  factor a, initiate  signal  transduction  pathways 
that  converge  upon  the  NF-KB-IKB  complex,  resulting in 
the  dissociation of IKB  and  the  translocation  of  NF-KB  to 
the  nucleus. It has  been  demonstrated  that  the  phospho- 
rylation of IKB is associated  with  NF-KB  activation, al- 
though the kinasecs)  responsible  for  this  process in uiuo 
remain  unknown.  Here  we  demonstrate  that  expression 
of activated  forms  of  the  GTP-binding  protein Ras or  of 
the  serindthreonine  kinase Raf.1 results in the  activa- 
tion  of  transcription  specifically  through KB sites. This 
activation  appears  to  be  dependent  on  NF-KB,  since  co- 
expression of IKBa eliminates  both Ras- and Raf-l-in- 
duced  transcription. In addition,  through  the use of a 
dominant  negative  form  of  Raf-1,  we  show  that  Raf-1 is   
common  component utilized by multiple  inducers  in KB 
site-driven  gene  expression.  These  results  illuminate  a 
signal  transduction  pathway  in  which  m-KB/Rel  family 
members  participate  and  also  implicate  a  pathway  re- 
sponsible  for KB site-dependent  gene  expression  during 
cell  growth  and  in  immune  and  inflammatory  responses. 
The proto-oncogene c-raf is the  cellular homolog of v-raf, the 
acutely transforming  gene of the  avian  sarcoma  virus 3611 (1). 
The c-raf gene encodes a ubiquitous  serindthreonine  kinase, 
which is  activated by a large  variety of signals originating at 
the cell surface (Ref. 2; for review, see Ref.  3). Expression of the 
Raf-1  kinase activity is believed to play an  essential role in 
mediating  the  transfer of these  signals from the cell surface  to 
the nucleus. In  agreement  with this view, Raf-1 expression can 
result  in  the induction of transcription from both  cellular  and 
viral  promoters (4-7). A large body of work has  recently  iden- 
tified  Raf-1 as an  essential  downstream effector molecule of the 
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membrane localized proto-oncogene product Ras (8-10). Like 
Raf-1, Ras is thought  to  be a key signal-transducing molecule 
involved in  the process of cell growth  and  differentiation  and  is 
activated by various  extracellular  stimuli (for review, see Ref. 
11). Two other  participants  in this pathway, MAP’ kinase ki- 
nase  and M A P  kinase, lie downstream of Raf-1 and  can  them- 
selves phosphorylate  and  activate  additional  kinases  or  other 
proteins,  such  as  transcription  factors (for review, see Ref. 12). 
Transcription factors that comprise the   NF-KB/R~~ family are 
important  participants  in  the  regulation of many  immune func- 
tion  and  inflammation  response  genes as well as in  the  regu- 
lation of viral  gene expression, including that of the  human 
immunodeficiency virus (HIV) (for reviews, see Ref. 13-15). 
The most well characterized complex containing NF-KB/Rel 
family members,  termed  NF-KB, is a heterodimer composed of 
a 50-kDa (NFKB1) protein, derived from a 105-kDa  precursor, 
and a 65-kDa protein (RelA) (14, 15). Other  members of the 
NF-KB/Rel family include c-Rel, RelB, and p52/p100 (NFKBB) 
(14, 15). Various homo- and heterodimeric combinations of 
these family members  can be  formed in vitro and detected in 
vivo and  are likely to be unique  in at least some aspects of 
function. In  addition, some members of the NF-KB/Rel family 
can functionally and physically interact  with  unrelated  tran- 
scription factors  such as CIEBPO, also known as NF-IL-6 (16, 
17). 
NF-KB is typically localized in the cytoplasm where it is 
complexed to its inhibitor,  IKB (18). Several forms of IKB  have 
been identified, including I K B ~  and I K B ~  (19). Activation of 
NF-KB involves  dissociation of IKB, allowing active  NF-KB  to 
translocate to  the  nucleus  and  transcriptionally  regulate  target 
genes (18,20-22). In vitro experiments  have  demonstrated that 
phosphorylation of IKB  eliminates  its  ability  to  interact  with 
NF-KB (23,241. More importantly,  it  has recently  been shown  in 
vivo that  the  activation of NF-KB  is accompanied by the phos- 
phorylation (20) and  subsequent loss of I K B ~  (20-22). However, 
the  kinases responsible for this  post-translational modification 
remain unknown. NF-KB,  Ras, and Raf-1  are  all  activated by 
many of the  same processes,  including treatment of cells with 
growth factors  (2,25-27), stimulation  with  the  tumor  promoter 
PMA (2, 28, 29), and  activation of the T-cell receptor  (28, 30, 
31). These  observations,  in conjunction with  the  apparent role 
of phosphorylation in  NF-KB  activation, prompted an investi- 
gation of whether a signal transduction  pathway  containing 
Ras  and Raf-1 could contribute to  the  activation of NF-KB. 
MATERIALS AND METHODS 
Cells and TFansfections-Balbfc 3T3 cells, obtained  from  American 
Type Culture Collection,  were maintained  in Dulbecco’s modified Ea- 
gle’s  medium  supplemented  with 10% calf serum, penicillin,  and strep 
tomycin. DNA transfections were performed  by the calcium  phosphate 
precipitation  method.  Cells were seeded 24 h prior to transfection at 1 
x IO6 cells/100-mm plate. A precipitate was  left on the cells for approx- 
imately 16 h, after which the cells were  washed  with  phospbate-buff- 
ered  saline;  subsequently,  fresh  medium,  containing  0.5%  serum, was 
added.  The  plasmid  pGEM was used to  equalize the amount of DNA 
transfected in each  experiment  to  15  pg. In all  experiments  cells were 
incubated for  an additional 48 h, then harvested, and the CAT activity 
phorbol 12-myristate 13-acetate;  TNFa,  tumor  necrosis factor a; CAT, 
The abbreviations used are: M A P ,  mitogen-activated protein; PMA, 
chloramphenicol acetyltransferase; HIV,  human  immunodeficiency vi- 
rus; LTR,  long terminal  repeat;  CEBP, CCAAT/enhancer-binding  pro- 
tein. 
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determined. In indicated experiments, either TNFa, PMA, or serum 
was added 24 h prior to  harvest. TNFa (obtained from Promega) was 
added to a final concentration of 10 ngfml, PMA (obtained from Sigma) 
was added to a final concentration of 100 ngfml, and for experiments 
involving induction by serum, the medium containing 0.5% serum was 
removed and fresh medium containing 10% serum added. In all cases, 
1 unit of relative activity represents the CAT activity obtained after 
transfection of the reporter gene alone. All experiments were  performed 
at  least three times with similar results. 
Plasmids-Plasmids encoding RafBXB, Raf301, v-H-Ras, and the 
B4X reporter were a kind gift of U.  R. Rapp and are described elsewhere 
(32). The ~X-KB-CAT  and 3x-mut~B-CAT (26), the HIV-LTR-CAT and 
HIV-AKB-CAT  (311, and  the I K B ~  expression vector (33) have been de- 
scribed previously. Multiple preparations of each plasmid were used in 
the experiments. 
CAT  Assay-Cells were washed, scraped in phosphate-buffered sa- 
line, pelleted in a centrifuge, and resuspended in 0.25 M Tris, pH 7.6. 
Cells were then lysed by freeze-thaw and the  supernatant collected 
after pelleting to remove cellular debris. Equal amounts of protein, as 
determined by the Bradford assay (Bio-Rad), were then analyzed for 
chloramphe~col acetyltransferase activity using the fluor diffusion as- 
say (34). 
RESULTS 
Ras and  Rap1 Activate Transcription through NF-KB Bind- 
ing Sites-It was first determined whether the constitutively 
activated forms of Ras and Raf-1,  v-H-Ras and RafBXB, respec- 
tively,  could activate  transcription  through NF-KB binding sites 
in transient transfection assays. RafBXB lacks the amino-ter- 
minal domain, which functions to negatively regulate Raf-1 
kinase activity. This deletion results in a constitutively active 
form of the protein (3, 32). These initial experiments utilized 
the reporter ~X-KB-CAT, which contains three copies of the 
class I major histocompatibility complex KB site. A similar con- 
struct, ~X-~U~KB-CAT,  containing three  mutated KB sites, was 
also used. The  mutated KB sites have been  shown  previously to 
be unresponsive to NF-KB (26). The results shown in Fig. lA 
indicate that co-transfection into Balb/c 3T3 cells of vectors 
encoding v-H-Ras and  the  reporter plasmid ~X-KB-CAT led to a 
greater than 4-fold induction of gene expression. Since Raf-1 
has been  shown to lie downstream of Ras  in  other signal trans- 
duction pathways, it was of interest to determine if it too  could 
activate transc~ption through KB sites. Co-transfection of Raf- 
BXB with ~X-KB-CAT resulted in a 12-fold activation of tran- 
scription (Fig. lA 1, indicating that  this serine/threonine kinase 
can  activate gene expression through  a KB site. To investigate 
whether these results could be demonstrated for KB sites in 
their  native DNA context, we utilized a  reporter plasmid con- 
taining the HIV-LTR attached  upstream of the CAT gene (HIV- 
LTR-CAT). Previous studies have demonstrated that  the KB 
sites found within the HIV-LTR bind NF-KB and significantly 
contribute to its transcriptional induction (31). Co-transfection 
of either RafBXB or v-H-Ras expression vectors with HIV-LTR- 
CAT resulted in 8- and 4-fold stimulation of gene expression, 
respectively (Fig. 1B).  Neither  the 3x-mut~B-CAT reporter nor 
a reporter containing mutated KB sites within the HIV-LTR 
linked to CAT (HIV-AKB-CAT) were activated when co-trans- 
fected with either RafBXB or v-H-Ras, demonstrating that  the 
observed activation occurred  specifically through functional KB 
sites (Fig. l ,A and B) .  Moreover, the vector in which RafBXB is 
inserted was not responsible for the KB site-dependent induc- 
tion of gene expression since it did not activate transcription 
when containing an insert encoding a kinase-deficient form of 
Raf-1 (data not shown). These results confirm previous work 
indicating that  the HIV-LTR KB sites  are responsive to  Ras (35) 
and further demonstrate that the serjne/threonine kinase 
Raf-1 can mediate transcriptional induction specifically 
through NF-KB binding sites. 
IKBa Specifically Inhibits Transcriptional Activation by Ras 
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through NF-KB binding sites. Balb/c 3T3 cells  were transfected with 
RG. 1. Ras and Raf-1 activate gene expression specifically 
5 pg of reporter plasmid either alone or together with 5 pg of plasmid 
encoding v-H-Ras or  RafBXB  by the calcium phosphate procedure as 
described under "Materials and Methods."  A, 3X-KB-CAT or 3X-mut~tB- 
CAT were transfected alone  or together with v-H-Ras or RafBXB. B, 
HIV-LTR-CAT or HIV-AKB-CAT were transfected alone or with v-H-Ras 
or RafBXB. Results obtained using reporters containing functional KB 
sites ~X-KB-CAT or HIV-LTR-CAT are indicated with striped bars, and 
those using mutated KB sites 3x-mut~B-CAT or HIV-AKB-CAT are in- 
dicated with solid burs. The presence of v-H-Ras or RafBXB is indicated 
at the bottom  of the histogram. The average and  standard  error of three 
separate experiments is shown. 
ulation of the NF-KBiRel family of transcription factors (19, 
20-22). I K B ~  inhibits NF-KB activity by sequestering it  in  the 
cytoplasm and by inhibiting its DNA binding capacity (33, 36). 
Both of these properties of I K B ~  are specific  for members of the 
NF-KB/Rel family of proteins (36). If  NF-KB/Rel family mem- 
bers are mediating the induction of transcription observed by 
Ras and Raf-1, it may be possible to inhibit this activation by 
the introduction of IKBCX. The co-transfection of vectors encod- 
ing v-H-Ras or RafBXB with ~X-KB-CAT resulted in a strong 
induction of transcription, as shown  above and  in Fig, 2 A .  Co- 
transfection of I K B ~  with RafBXB or v-H-Ras and ~X-KB-CAT 
resulted in a complete inhibition of activation. Essentially iden- 
tical results were obtained using the HIV-LTR-CAT reporter 
plasmid (data not shown). The parent vector in which I K B ~  is 
inserted, psoCmin, had only a minor  effect on activation by Ras 
and Raf-1 (data not shown). To determine if the inhibition by 
I K B ~  was specific  for KB  sites, the ability of IKBQ  to inhibit Ras 
and Raf-1 transcriptional activation through an AP-l/Ets  site 
was tested. Previous studies have shown that Ras and Raf-1 
induce expression from the AP-l/Ets  site found within the en- 
hancer of the polyomavirus (4, 32, 37). Co-transfection of  vec- 
tors encoding  v-H-Ras or  RafBXB with B4X, a reporter plasmid 
containing four  copies of the AP-lmts site  upstream of CAT, 
resulted in an 8- or  17-fold activation, respectively (Fig. 2B). 
When IuBa was co-transfected with RafBXB or v-H-Ras and 
B4X, absolutely no inhibition was observed, demonstrating 
that  the inhibitory effect of IuBa was specific  for KB sites  and 
also that I K B ~  did not alter  the expression or directly inhibit 
the activity of v-H-Ras or RafBXB. Analysis of  RafBXB protein 
levels by Western blot  confirmed that  its expression was not 
inhibited in the presence of I K B ~  (data not shown). The ability 




mediated through NF”& binding sites but  not AP-1IEts sites. A, 
FIG. 2. IKBa inhibits Ras- and Raf-1-induced gene expression 
BalWc  3T3 cells were  transfected either with 5  pg of ~X-KB-CAT alone, 
together with 5 pg of  v-H-Ras  or RafBXB encoding plasmid, or with 5 pg 
of the plasmids encoding v-H-Ras or RafBXB as well as 0.25 pg of the 
IKBa-expressing plasmid. B,  cells were transfected with the same com- 
binations of plasmids as described inA except that 1 pg of  B4X  reporter, 
which contains four copies of the AP-1Ets binding site fused upstream 
of  CAT, was used in place of ~X-KB-CAT. The striped burs indicate the 
results obtained in the absence of I K B ~ ,  and the solid bars indicate the 
results in its presence. The  presence of v-H-Ras or RafBXB is indicated 
below the histograms, and the reporter used is indicated above each 
figure. The average and  standard  error  of three separate experiments is 
and Methods.” 
shown. Transfections were performed as described under “Materials 
of I K B ~  to inhibit Ras- and Raf-1-induced gene expression from 
KB site-driven reporters may indicate that  this inhibitor is not 
a direct target of this pathway. Alternatively, the high level 
expression of I K B ~  following transfection may “mask” direct 
inactivation through the R a a f  pathway by providing a large 
pool of unmodified proteins able to inhibit NF-KB activity. In 
any case, these  results suggest that members of the NF-KB/Rel 
family of transcription factors are  targets of a signal transduc- 
tion pathway containing Ras and Raf-1 that results  in activa- 
tion through KB sites. 
Serum-, PMA-, and T N ~ a - i n d u ~ e d  Expression from a KB 
Site-driven Promoter Utilizes Raf-1-The transcription factor 
NF-KB  and the signal-transducing molecules Ras and Raf-1 are 
activated by many of the same  agents, including serum  and the 
tumor promoter PMA. This observation, in addition to the 
above results, prompted an investigation into  whether Raf-1 is 
a component of the signal transduction pathways initiated by 
serum or PMA that results in gene expression mediated 
through KB sites. Moreover, it was of interest to determine if 
other inducers of NF-KB, such as TNFa (381, also made use of 
Raf-1 in  the activation of gene expression from KB sites. A 
dominant negative form of Raf-1 (Raf301) was utilized in  these 
experiments. The lysine comprising the ATP binding site of 
Raf-1 was converted to a tryptophan in RaBOl (8, 321, elimi- 
nating its kinase activity and, more importantly, creating a 
protein with dominant negative properties specific  for  endoge- 
nous Raf-1 activity (32). The ability of Rat301 to inhibit Ras- 
induced gene expression through KB sites (data not shown) 
demonstrates that Raf-1 is downstream of Ras in this pathway 
and, furthermore, suggests that Raf301 should  effectively  block 
serum-, PMA-, and, TNFa-induced gene expression through a 
KB site if they also utilize Raf-1 in  this process. The addition of 
either serum, PMA, or TNFa to quiescent Balbk 3T3 cells 
subsequent to transfection with the ~X-KB-CAT  reporter e- 
sulted in 6-, 2-, or 12-fold activation respectively, as shown in 
Fig.  3. The participation of members of the N F - K B ~ ~  family 
was demonstrated by the ability of co-transfected I K B ~  to in- 
hibit  stimulation of ~X-KB-CAT by all  three inducers (Fig. 3). 
When the vector  encoding the dominant negative form of Raf-1 
(Raf301) was co-transfected with ~X-KB-CAT  and the cells then 
stimulated with PMA, serum, or TNFa as before, a significant 
reduction in the inducibility of ~X-KB-CAT was observed (Fig. 
3). Similar results were observed with the HIV-LTR-CAT re- 
porter (data not shown). The inability of Raf301 to completely 
suppress activation by the inducers tested (including Ras) may 
reflect inefficiencies in its inhibitory function. This view is sup- 
ported by the observation that other dominant negative forms 
of Raf-1 more  effectively inhibited wild-type Raf-1 activity (32) 
and by the inability of other investigators to see complete in- 
hibition by Raf301 (32, 39, 40). Alternatively, additional KB 
site-specific pathways downstream of Ras that do not include 
Raf-1 may exist. Neither of the reporters containing mutated 
KB sites, 3x-mut~B-CAT or HIV-AKB-CAT, were induced by 
serum, PMA, or TNFa, verifying that  the observed results oc- 
curred specifically through NF-KB binding sites (data not 
shown). Since the dominant negative form of Raf-1 specifically 
inhibits endogenous Raf-1 activity (321, it can be  concluded that 
Raf-1 is a necessary component in  semm-, PMA-, and TNFa- 
induced transcription from KB site-dependent promoters. 
DISCUSSION 
The simplest interpretation of the  data presented, when con- 
sidered together with the apparent role of phosphorylation in 
NF-KB activation (20, 23,  24), is that Raf-1 itself or a kinase 
downstream of Raf-1 directly phospho~lates  the NF-KBIIKB 
complex, resulting in  the dissociation of IKB  and  the translo- 
cation of active NF-KB to the nucleus. However, other mecha- 
nisms could also explain the results presented. For example, it 
is conceivable that neither NF-KB nor IKB are post-translation- 
ally modified  by this pathway but  instead  the immediate target 
is an unrelated molecule that can interact  with NF-KB. Mem- 
bers of the  CEBP  and AP-1 transcription factor families both 




serum PMA TNFa 
FIG. 3. Multiple inducers of NF-KB utilize Raf-1 in & site-de- 
pendent gene expression. 5 pg of  3X-KB-CAT  reporter  plasmid was 
transfected either alone or together with 0.25 or 5 pg of  plasmid ex- 
pressing I K B ~  or RafjOl respectively. For the indicated experiments, 
cells were stimulated with either serum (final concentration = lo%), 
TNFa (final concentration = 10 ngiml), or PMA (final concentration = 
absence of RaBO1 or I K B ~ ,  solid bars are  in the presence of I K B ~ ,  and 
100 ngiml) 24 h  prior to harvest. Striped bars are results obtained  in the 
open bars are in the presence of RaBO1. The inducers are indicated 
The average and standard error  of three separate experiments is 
below the histogram and the reporter used is shown above the figure. 
shown. Transfections  and the addition of inducers  were as described 
under  “Materials  and Methods.” 
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physically and functionally interact with NF-KB  subunits (16, 
17).2 Furthermore, their transcriptional activity is enhanced by 
direct phosphorylation mediated by a pathway containing Ras 
(42, 43). In  this scenario, AP-1 and/or C/EBP family members 
would  be directly phosphorylated by this pathway, modifying 
their interaction with  NF-KB,  and  resulting  in  a complex with 
both KB site-specific binding activity and enhanced transcrip- 
tional inducibility. Although NF-KB would not be directly tar- 
geted, its transactivation ability would be enhanced by the 
altered interaction with phosphorylated AP-1 andor C/EBP 
members. 
Although Ras and Raf-1 have been generally investigated 
and characterized in terms of their role in cell growth and 
differentiation, another function of these proteins is in the 
transduction of signals  during immune and inflammation re- 
sponses. For example, engagement of the T-cell receptor or 
interaction of the lymphokine interleukin-2 with its receptor 
results  in  the activation of Ras, Raf-1, and likewise NF-KB (28, 
30,31,44,45). The evidence presented here indicates that  the 
inflammatory cytokine TNFa also utilizes Raf-1 in KB site- 
dependent activation of transcription, an observation that  is 
supported by preliminary data demonstrating that TNFa treat- 
ment of Balblc  3T3 cells results  in a modified  form of the Raf-1 
p r ~ t e i n . ~  The presence of this slower migrating form of Raf-1 on 
a SDS-PAGE  gel has been shown to correlate with the induc- 
tion of Raf-1 kinase activity (3). It is conceivable that additional 
agents that activate NF-KB during immune and inflammation 
responses do so through a signal transduction pathway con- 
taining Ras and Raf-1. 
An increasing amount of evidence suggests that NF-KB is 
required during cell proliferation. For instance,  NF-KB activa- 
tion has been observed to occur  specifically during  the Go-GI 
phase in 3T3 fibroblasts (261, a time when various immediate 
early genes are activated, including the proto-oncogene c-myc 
and  the melanoma stimulatory factor-encoding gene, gro (46, 
47). Interestingly, the promoter regions of both these genes 
contain KB sites, and, more importantly, these sites are re- 
quired for their induction in response to various stimuli (48, 
49). Further evidence implicating NF-KB in  the regulation of 
cell growth is the discovery that truncated (v-Rel), overex- 
pressed (Bcl-31, differentially spliced (p65A), and rearranged 
(Lyt-10) members of the NF-KB or IKB family are potentially 
oncogenic (14, 50). Finally, it has been demonstrated that  at 
least one type of transformed cell, fibroblasts transformed by 
the  human T cell leukemia virus-1 Tax protein, can be reverted 
to the non-transformed state through the inhibition of NF-KB 
activity (41). These observations, when considered together 
with the ubiquitous nature of NF-KB and its activation by a 
diverse group of agents, strongly suggest a more general role 
for this  transcription factor in the regulation of  cell growth. 
The activation of  NF-KB/Rel family members by growth stim- 
ulatory proteins such as Ras and Raf-1 is consistent with the 
known function of these proteins during cellular proliferation 
and in immune and inflammation responses. Although it is 
presently unclear whether members of the NF-KB4X.d family 
are directly activated by the signal transduction pathway de- 
fined here, it is apparent  that  the transcription factors that 
comprise this family are important in  the conversion  of signals 
carried by Ras and Raf-1 in the cytoplasm to changes in gene 
expression within the nucleus. 
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